Summary
- Current Price
- As of today, RCKT price is $3.86, up +3.49% on
- Current Price All-Time High
- RCKT price is currently -95.04% below its historical high of $77.80 set on
- Market Cap
- RCKT current market cap is $424M, up +21.22% over the past 365 days
- Revenue
- RCKT current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for RCKT is on
Profile
| Metric | Value |
|---|---|
| Full Name | Rocket Pharmaceuticals, Inc. |
| Ticker | NASDAQ: RCKT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | rocketpharma.com |
| Employees | 299 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $3.86 | |
| Price, 1D Change | +3.49% | |
| $424M | ||
| - | ||
| - | ||
| 1.90 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.01 | ||
| EPS, 1Y Change | +26.43% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:4 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ITEK | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$2.01 | ||
| EPS Estimate | -$0.11 | N/A |
| EPS Est. Change | +94.65% | N/A |
| $0.00 | ||
| Revenue Estimate | $1.11M | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $3.86 | |
| Price Target | $10.00 | - |
| Price Tgt. Change | +159.07% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.80 | -$2.73 | +2.69% | |
| -$2.01 | -$2.01 | +0.28% | |
| -$0.11 | N/A | +94.65% | |
| -$1.30 | N/A | +35.16% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $28.45K | $0.00 | -100.00% | |
| - | $0.00 | - | |
| $1.11M | N/A | - | |
| $11.46M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $3.86 | |
| $3.57 | ||
| $3.53 | ||
| $3.85 | ||
| $3.51 | ||
| $0.09 | ||
| 1.90 | ||
| $0.21 | ||
| 60.09 | ||
| 64.70% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$2.01 | ||
| $0.00 | ||
| - | ||
| -$228.52M | ||
| - | ||
| -$223.12M | ||
| - | ||
| -$217.49M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.09 | ||
| 6.38 | ||
| 6.38 | ||
| - | ||
| - | ||
| -0.74 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 1.15 | ||
| -0.90 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $277.22M | ||
| $188.93M | ||
| $330.45M | ||
| $192.73M | ||
| $53.23M | ||
| $30.21M | ||
| $24.88M | ||
| $2.92M | ||
| $0.00 |
Expenses
| Metric | Value | Date |
|---|---|---|
| $223.12M | ||
| $217.49M | ||
| $11.03M | ||
| $86.50M | ||
| $11.03M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$190.05M | ||
| $103.77M | ||
| $183.00K | ||
| $440.00K | ||
| -$190.49M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wedbush | → | |
| Chardan Capital | → | |
| B of A Securities | → | |
| Chardan Capital | → | |
| Goldman Sachs | → | |
| Cantor Fitzgerald | → | |
| JP Morgan | → | |
| B of A Securities | → | |
| Chardan Capital | → | |
| Leerink Partners | → |
Analyst sentiment
Institutional ownership
No data
Screeners with RCKT
FAQ
- What is the ticker symbol for Rocket Pharmaceuticals, Inc.?
- The ticker symbol for Rocket Pharmaceuticals, Inc. is NASDAQ:RCKT
- Does Rocket Pharmaceuticals, Inc. pay dividends?
- No, Rocket Pharmaceuticals, Inc. does not pay dividends
- What sector is Rocket Pharmaceuticals, Inc. in?
- Rocket Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is Rocket Pharmaceuticals, Inc. in?
- Rocket Pharmaceuticals, Inc. is in the Biotechnology industry
- What country is Rocket Pharmaceuticals, Inc. based in?
- Rocket Pharmaceuticals, Inc. is headquartered in United States
- When did Rocket Pharmaceuticals, Inc. go public?
- Rocket Pharmaceuticals, Inc. initial public offering (IPO) was on February 18, 2015
- Is Rocket Pharmaceuticals, Inc. in the S&P 500?
- No, Rocket Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is Rocket Pharmaceuticals, Inc. in the NASDAQ 100?
- No, Rocket Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is Rocket Pharmaceuticals, Inc. in the Dow Jones?
- No, Rocket Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was Rocket Pharmaceuticals, Inc. last earnings report?
- Rocket Pharmaceuticals, Inc.'s most recent earnings report was on August 10, 2026
- When does Rocket Pharmaceuticals, Inc. report earnings?
- The next expected earnings date for Rocket Pharmaceuticals, Inc. is November 5, 2026
Data Sources & References
- RCKT Official Website www.rocketpharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1281895/000119312526076551/0001193125-26-076551-index.htm
- RCKT Profile on Yahoo Finance finance.yahoo.com/quote/RCKT
- RCKT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rckt